(1). As to carcinogenic risk, there is evidence for synergism Email: sdf@unige.it between CS and exposure to arsenic, asbestos, ethanol, silica A combination of tobacco smoking with certain agents has and radiation (radon, atomic bomb emissions and X-rays), been shown to exert synergistic carcinogenic effects. On whereas there is antagonism with chloromethyl methyl ether the other hand, antagonism betweeen smoke and other and bis(chloromethyl) ether (2, 3) . pulmonary carcinogens has also been documented by both For many other carcinogens, however, the power of epidemiological and experimental data. In spite of a very epidemiological studies is insufficient to pinpoint interactions large number of studies carried out for decades in workers with CS. Indeed, CS represents a major confounding factor, exposed to hexavalent chromium, the influence of smoking especially when evaluating the health effects of other airborne habits on lung carcinogenesis induced by this metal has agents. The situation is complicated by the fact that CS is a not been clarified. For this reason, we performed two complex mixture. More than 3040 chemical compounds have studies evaluating clastogenic effects in rodents. In the first been isolated from processed tobacco leaf and MCS contains one, BDF 1 mice were exposed whole-body to mainstream nearly 4000 identified chemicals plus an unknown number of cigarette smoke for 5 days and, on the last day, they unidentified chemicals (4) . Since many of these compounds, received an i.p. injection of potassium dichromate. In the which belong to a variety of chemical families, have toxicological relevance and work by different mechanisms (3), it is second study, Sprague-Dawley rats were exposed wholedifficult to assess the overall impact on human health of an body to environmental cigarette smoke for 18 consecutive interaction between CS and other chemicals, even in the days and for the same period of time they received daily workplace, where in principle exposures are more accurately intra-tracheal instillations of sodium dichromate. Individudefined. ally, the two hexavalent chromium salts and cigarette This is the case for the interaction between CS and Cr(VI). smoke, either mainstream or environmental, enhanced the At variance with metallic chromium and Cr(III), there is frequency of micronuclei in bone marrow polychromatic sufficient evidence for the carcinogenicity of Cr(VI) in the erythrocytes of both mice and rats. Moreover, individual human lung, at least at the high doses which are encountered exposure to either environmental cigarette smoke or sodium in certain occupational settings (5,6). In spite of a very large dichromate enhanced the frequency of micronuclei and number of studies on Cr(VI)-exposed workers which have multiple nuclei in pulmonary alveolar macrophages of rats.
been carried out world wide for several decades, epidemiologIn both studies, combined exposure to cigarette smoke ical studies have not clarified whether combined exposure and hexavalent chromium produced less than additive to CS and Cr(VI) has synergistic, additive or antagonistic clastogenic effects. These results are consistent with our effects (7) . previous data, showing that hexavalent chromium and Due to the lack of information provided by epidemiological either benzo[a]pyrene or cigarette smoke condensate studies and to the fact that, for different reasons, it is very behave antagonistically in in vitro mutagenicity test systems difficult to reproduce the lung tumorigenicity of both Cr(VI) and that the chromium reducing capacity of human pul-(5) and CS (3, 8) in animal models, we designed a study aimed monary alveolar macrophages and peripheral lung parenat evaluating the interaction between CS and Cr(VI) in inducing chyma is enhanced in smokers. Taken together, in the clastogenic effects in rodents. With this goal in mind, we absence of any epidemiological evidence, these findings rule performed two separate experiments. In the first one, we out any occurrence of synergism between cigarette smoke exposed whole-body BDF 1 mice to MCS and/or to Cr(VI), and hexavalent chromium, at least in certain stages of the given i.p., and measured the frequency of micronucleated carcinogenesis process.
(MN) polychromatic erythrocytes (PCE) in bone marrow. In the second experiment, we exposed whole-body SpragueDawley rats to ECS and/or Cr(VI), given intra-tracheally (i. combination is less than additive.
Materials and methods

Animals
The experiments in mice and rats were carried out in the Sofia laboratory and the Genoa laboratory, respectively. Male BDF 1 (C57BLϫDBA 2 ) mice, aged 8-12 weeks and weighing 23-25 g, were from the Animal Laboratory, National Centre of Oncology (Sofia, Bulgaria). Male Sprague-Dawley rats, aged 6-8 weeks and weighing 180-200 g, were purchased from Harlan Italy (Correzzana, Milan, Italy). The animals were housed in plastic cages on sawdust bedding and maintained on standard rodent chow and tap water ad libitum. The temperature of the animal rooms was 23 Ϯ 2°C, with a relative humidity of 55% and a 12 h day/night cycle. The housing and treatment of animals were in accordance with national and institutional guidelines.
Treatment of mice
After acclimatization for 2 weeks, BDF 1 mice were divided into four groups, each composed of 10 animals, and treated as follows: (i) sham-exposed mice, kept in filtered air and receiving an i.p. injection of 200 µl of 0.15 M NaCl after 5 days; (ii) mice exposed to MCS for 5 days; (iii) mice receiving a single i.p. injection of potassium dichromate (K 2 Cr 2 O 7 ) (E. Merck, Darmstadt, Germany), dissolved in 200 µl of 0.15 M NaCl at a dose of 50 mg/kg body wt; (iv) mice exposed to MCS for 5 days and, on day 5, receiving a single Fig. 1 . Frequency of MN PCE and PCE/NCE ratio in bone marrow cells of i.p. injection of potassium dichromate. A whole-body exposure to MCS was male BDF 1 mice, either sham-exposed (controls) or exposed whole-body to obtained, as previously described (9), using filter-tipped commercial cigarettes MCS for 5 consecutive days or receiving a single i.p. injection of potassium (Arda-Bulgartabac) that have a declared content of 31.5 mg tar and 1.6 mg dichromate [Cr(VI)] or exposed to both agents [MCS ϩ Cr(VI)]. Each nicotine. Briefly, each of the groups of mice undergoing this treatment was symbol indicates the value observed in each animal. Mean Ϯ SD values placed in a 22.5 l sealed glass chamber that was subsequently filled by means within each group of 10 mice are also shown. of a 50 ml syringe with the MCS generated by one cigarette. The chamber was opened after 10 min and, after a 1-2 min interval needed to renew the air, filled again with fresh smoke for a total of nine times, for 5 consecutive
Results
days. The concentration of total particulate matter (TPM) in the exposure chamber was, on average, 533 mg/m 3 air. were all moderately toxic to bone marrow cells, as shown by (89%) and mainstream smoke (11%), mimicking exposure to ECS. Based on a slight but significant decrease in the PCE/NCE ratio (P Ͻ preliminary experiments, we decided to burn 10 2R1 cigarettes at one time, 0.01 in all cases). 6 h/day, divided in two rounds with a 3 h interval. This accounted for a whole-body exposure to the smoke generated by 4320 cigarettes. Under these Clastogenic damage of environmental cigarette smoke and conditions, the TPM in the exposure chambers was 120 mg/m 3 air.
Clastogenic damage of mainstream cigarette smoke and/or
chromium(VI) i.t. in Sprague-Dawley rats Cytogenetic analyses
The results of this experiment are shown in ECS-exposed rats and 2.8‰ in Cr(VI)-treated rats. Hence, the The same conclusion was drawn by testing bone marrow cells from the same animals ( Figure 3 ). In fact, exposure to ECS, administration of Cr(VI) and the combined treatment yielded very similar increases in the frequency of MN PCE, i.e. 3.5-, 4.0-and 4.3-fold, respectively. Of the three treatment groups, only that including ECS-exposed rats exhibited a slight but significant (P Ͻ 0.01) decrease in the PCE/NCE ratio.
Discussion
The results of the present study highlight the ability of both CS and Cr(VI) to induce clastogenic damage in animal models. At the same time, they rule out any occurrence of synergistic effects of the combined agents in affecting this type of early biological marker.
In spite of some negative findings, there is overwhelming evidence which supports the ability of CS to induce clastogenic effects in rodents. Thus, no significant effect was observed in studies evaluating sister chromatid exchanges (SCE) and chromosomal aberrations (CA) in bone marrow cells of CSexposed Chinese hamsters (13) , SCE in peripheral lymphocytes from Wistar II rats exposed whole-body to mainstream CS (14) and SCE, CA and MN in bone marrow cells of Sprague- exposed to CS, either nose-only or whole-body (18). An increased frequency of MN and binucleated PAM was observed in CBA/H mice exposed whole-body to CS (19). Furthermore, a CS condensate enhanced MN PCE in the bone marrow of NMRI mice treated i.p. (20) and, interestingly, sidestream smoke was more potent than mainstream smoke in producing this clastogenic effect (21).
In our laboratories, the whole-body exposure of BDF 1 mice to mainstream CS had previously been found to increase the frequencies of MN PCE in bone marrow (22), of MN NCE in peripheral blood (23) and, after transplacental passage, of MN PCE in fetal liver and in the liver and peripheral blood of newborn mice (24). Moreover, whole-body exposure to MCS enhanced the frequency of both MN PAM and MN PCE in Sprague-Dawley rats (25), BD 6 rats (26, 27) and Balb/c and BDF 1 mice (27). Recently, we investigated the time course of induction and persistence of cytogenetic alterations in cells of BDF 1 mice exposed whole-body to mainstream CS for 3 weeks. The frequency of MN PCE increased early in exposure but declined to background levels upon discontinuation of exposure to CS. The appearance of MN NCE in peripheral blood was slightly delayed but persisted for an additional 3 addition, they show the occurrence of cytogenetic alterations in Sprague-Dawley rats exposed to ECS. In particular, CS induced in both mice and rats a significant increase in MN expected additive frequency would have been 4.4‰, versus the observed 3.6‰ in the combined treatment group. Similarly, PCE and was slightly toxic to bone marrow cells, as shown by a modest but significant decrease in the PCE/NCE ratio. the net frequency of PN PAM was 71.4‰ in ECS-exposed rats and 60.5‰ in Cr(VI)-treated rats. Hence, the expected Moreover, ECS induced clastogenic damage in the lower respiratory tract of rats, which was documented by an enhanceadditive frequency would have been 131.9‰, versus the observed 73.6‰ in the combined treatment group. ment of MN PAM and PN PAM. The latter type of alteration is regarded as the result of a cytokinesis failure or block after of 17.5 mg via the respiratory route in a man weighing 70 kg and therefore it would mimic exposure of a man to air completion of nuclear division, due to disruption of the cellular skeleton, rendering the production of additional genetic damage containing~1 mg/m 3 sodium dichromate [0.37 mg Cr(VI)/ m 3 ], which is a very high dose. The Cr(VI) reducing ability more probable (9) . Under the same conditions and in the same rat strain, ECS induced the formation of nucleotide alterations, of PAM is~2 µg/10 6 cells in both rats (45) and non-smoking humans (46). A further defence mechanism of the lower detected by 32 P-post-labeling in the tracheal epithelium, bronchoalveolar lavage cells, lung, heart, bladder and testis (28) . respiratory tract is provided by the epithelial lining fluid (ELF), which is particularly rich in antioxidants, such as reduced Hundreds of results document the ability of Cr(VI) compounds, once available to target cells, to induce genetic and glutathione (GSH), vitamin C (ascorbic acid), vitamin E (tocopherol), superoxide dismutase, catalase, albumin, cerulorelated effects in a variety of in vitro test systems (reviewed in refs 29,30). In contrast, the majority of clastogenic surveillance plasmin, transferrin, lactoferrin and other proteins (47) . The human ELF, which has been estimated to have a total Cr(VI) studies among Cr(VI)-exposed workers yielded negative or inconclusive results (reviewed in ref. 31 ). The conflicting reducing capacity of 0.9-1.8 mg (32) , is particularly rich in GSH (48), whereas in rats the Cr(VI) reducing activity of this nature of these data can be interpreted by taking into account the ability of the host organism to reduce and detoxify Cr(VI).
fluid has mainly been ascribed to ascorbic acid (49). The results obtained in the present study provide evidence that the These mechanisms, which attenuate the potential toxicity and carcinogenicity of Cr(VI), have been evaluated in quantitative exposure regimen to sodium dichromate (4.5 mg/kg body wt instilled over 18 days) was sufficient to produce cytogenetic terms in human body compartments (32) .
The majority of in vivo studies in rodents showed the ability damage in PAM, which were directly exposed, as well as in PCE, after transportation of Cr(VI) in amounts escaping of soluble Cr(VI) compounds to induce cytogenetic damage, but less consistently than in in vitro models (29). Moreover, detoxification in the blood. The results of the two experiments described herein show most in vivo studies involved administration routes which do not mimic any human exposure and used 'excessive' doses that the clastogenic effects produced either by MCS in combination with Cr(VI) i.p. in mice or by ECS in combination with which can overwhelm the host defence mechanisms. For instance, the highly soluble Cr(VI) salts potassium dichromate Cr(VI) i.t. in rats are less than additive. This conclusion was drawn by analyzing both bone marrow cells and PAM, which and potassium chromate increased MN PCE in bone marrow cells of Chinese hamster and various mouse strains following were exposed to both agents at the high doses which are needed in experiments in animal models to yield positive i.p. administration of tens of milligrams of these compounds per kilogram body weight (33) (34) (35) (36) (37) (38) . Calcium chromate, which results. These data agree with the finding that no synergistic effect between CS and stainless steel welding was observed is slightly less soluble, was negative in both hamster and mouse when tested in comparative experiments under identical in the induction of chromosome damage in lymphocytes (50). Smokers usually show higher urinary chromium levels than conditions (34, 35) . Moreover, administration of up to 20 mg Cr(VI), in the form of potassium dichromate, either in drinking non-smokers (31), which might be ascribed to enhanced retention of particulates in the bronchial tree of smokers. An water or by gavage, failed to produce any effect in the mouse bone marrow micronucleus test (39) . This can be ascribed to alternative interpretation is that stimulation of Cr(VI) reduction by CS leads to increased urinary excretion of Cr(III). In fact, the potent detoxification of Cr(VI) in the gastrointestinal tract, especially due to reduction by gastric juice (32) .
in previous studies we showed that an MCS condensate attenuated the direct mutagenicity of Cr(VI) in strain TA100 Since the main goal of our study was to evaluate the occurrence of interactions between Cr(VI) and CS, we intenof Salmonella typhimurium, presumably due to the presence of reducing agents in this material. At the same time, Cr(VI) tionally chose experimental conditions which were expected to yield positive results. Thus, i.p. injection of potassium inhibited the metabolic activation of both MCS condensate and benzo[a]pyrene to mutagenic derivatives in strain TA98 dichromate at 50 mg/kg body wt produced an increase in MN PCE in mouse bone marrow, in agreement with the findings (51). An antagonistic effect between Cr(VI) and benzo[a]pyrene diolepoxide was recently shown by evaluating the freof the above referenced studies (33) (34) (35) (36) (37) (38) . Note that this would correspond to 3.5 g potassium dichromate [1.24 g Cr(VI)] quency of HPRT mutants in cultured human fibroblasts (52). The hypothesis that synergism may occur between CS and given i.p. to a man weighing 70 kg.
In the experiment using Sprague-Dawley rats, we adminisother agents, including carcinogenic metals, is often raised in the literature (1), but, with the previously reported exceptions, tered sodium dichromate i.t., since this type of administration bypasses the highly developed nasal filter of rodents and favors it is merely speculative and not substantiated by experimental or epidemiological data. It should be mentioned that antagonistic delivery of test agents to the lower respiratory tract (40) . The dose we selected (0.25 mg/kg body wt) was the same as has effects are also possible, as shown not only by epidemiological studies with methyl ethers (2,3), but also by animal studies been shown to produce a uniform distribution of sodium dichromate in rat lung (41) . Administration for 3 consecutive evaluating the combination of MCS with urethane (53) and of ECS with either urethane or 3-methylcholanthrene (8) in days caused DNA fragmentation, DNA-protein crosslinking, 32 P-post-labeled DNA modifications and an increase in 8-inducing lung tumors in mice.
From a mechanistic point of view, it is noteworthy that two hydroxy-2Ј-deoxyguanosine in the lung but not in the liver (42) . When given 5 days/week for 4 weeks, it autoinduced independent ex vivo studies in humans, both of them analyzing blind samples, demonstrated enhanced Cr(VI) reduction in the Cr(VI) metabolism in the lung (43) . When given for life, it failed to induce lung tumors (44). Therefore, it appears that respiratory tract of smokers. In particular, the PAM from 11 current smokers exhibited a Cr(VI) reducing capacity which this treatment induces several biomarkers in rat lung, as confirmed in the present study, but is not carcinogenic.
was significantly higher than that of either eight ex-smokers or four never-smokers (46). Similarly, preparations of periThe dose of 0.25 mg/kg body wt sodium dichromate, given i.t. for 18 consecutive days, would correspond to a daily intake pheral lung parenchyma from 45 smokers were significantly in PAM and bone marrow cells of rodents (this study). Thus,
